Corporate News 16-Nov-23
Board of Natco Pharma recommends Second Interim Dividend
Of Rs.1.25 per share
Natco Pharma announced that the Board of Directors of the Company at its meeting held on 14 November 2023, has recommended a Second Interim dividend of Rs.1.25 per share (i.e.62.5%), subject to the approval of the shareholders.
Previous News
Natco Pharma
( Results - Analysis 28-May-24 09:50 )
Indices turn rangebound; metal shares slide; VIX rises 3.93%
( Market Commentary - Mid-Session 04-Sep-24 12:36 )
Natco Pharma Ltd spurts 4.93%, up for third straight session
( Hot Pursuit - 07-Jun-24 13:05 )
Natco Pharma schedules AGM
( Corporate News - 12-Aug-24 16:48 )
Natco Pharma announces change in senior management
( Corporate News - 27-Jul-24 11:27 )
Natco Pharma
( Results - Analysis 30-May-23 11:27 )
Natco Pharma reports consolidated net profit of Rs 275.80 crore in the March 2023 quarter
( Results - Announcements 29-May-23 15:39 )
Natco Pharma Ltd spurts 2.15%, rises for fifth straight session
( Hot Pursuit - 04-May-23 13:01 )
Natco Pharma invests USD 8 mn in bio-tech firm eGenesis
( Corporate News - 04-Sep-24 12:07 )
Natco Pharma to table results
( Corporate News - 27-Jul-24 10:19 )
Natco Pharma fixes record date for 3rd interim dividend
( Market Beat - Reports 14-Feb-22 19:07 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
